Cargando…
Optimization of the production process for the anticancer lead compound illudin M: downstream processing
BACKGROUND: Secondary metabolites have played a key role as starting points for drug development programs due to their often unique features compared with synthetically derived molecules. However, limitations related to the discovery and supply of these molecules by biotechnological means led to the...
Autores principales: | Chaverra-Muñoz, Lillibeth, Briem, Theresa, Hüttel, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382783/ https://www.ncbi.nlm.nih.gov/pubmed/35978411 http://dx.doi.org/10.1186/s12934-022-01886-2 |
Ejemplares similares
-
Optimization of the production process for the anticancer lead compound illudin M: improving titers in shake-flasks
por: Chaverra-Muñoz, Lillibeth, et al.
Publicado: (2022) -
Optimization of the production process for the anticancer lead compound illudin M: process development in stirred tank bioreactors
por: Chaverra-Muñoz, Lillibeth, et al.
Publicado: (2022) -
A Chemical Proteomic Analysis of Illudin‐Interacting Proteins
por: Le, Philipp, et al.
Publicado: (2019) -
Large Scale Production and Downstream Processing of Labyrinthopeptins from the Actinobacterium Actinomadura namibiensis
por: Rupcic, Zeljka, et al.
Publicado: (2018) -
Unusual illudin-type sesquiterpenoids from cultures of Agrocybe salicacola
por: Liu, Liang-Yan, et al.
Publicado: (2011)